Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$crvs](/topic/$crvs)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$crvs/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$crvs/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XX% -X%  
**6 Months**: XX% +15%  
**1-Year High**: XXX% on 2025-01-10  
**1-Year Low**: XX% on 2025-01-24  

**Most Supportive Themes**
- **DeFi and Cross-Chain Potential:** (40%) Discussions around $CRVS's potential in the DeFi market and its growth, especially with cross-chain platforms.
- **Biopharma and Biotech Catalysts:** (30%) Positive developments in the biopharma sector, including discussions around $CRVS and its potential in autoimmune drug targets.
  
**Most Critical Themes**
- **Competition and Market Dynamics:** (10%)  Posts discussing the competitive landscape and how it may affect the market.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXXXX   | XX% | XX       | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXX   | XX% | XX       | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$crvs

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XX% -X%
6 Months: XX% +15%
1-Year High: XXX% on 2025-01-10
1-Year Low: XX% on 2025-01-24

Most Supportive Themes

  • DeFi and Cross-Chain Potential: (40%) Discussions around $CRVS's potential in the DeFi market and its growth, especially with cross-chain platforms.
  • Biopharma and Biotech Catalysts: (30%) Positive developments in the biopharma sector, including discussions around $CRVS and its potential in autoimmune drug targets.

Most Critical Themes

  • Competition and Market Dynamics: (10%) Posts discussing the competitive landscape and how it may affect the market.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXX XX% XXXXX XX% XX X%
Total XXXXX XX% XXXXX XX% XX X%
$crvs Sentiment
/topic/$crvs/sentiment